Pneumatic Components in Pharmaceutical Packaging Lines: Filling, Capping, Labeling, and Inspection

Specify each pneumatic component by location and product risk. A guarded cartoner cylinder after closure does not require the same controls as gas touching exposed product or a primary-container surface. Map actuators, valves, tubing, exhausts, and process-air outlets to stations and hygiene zones. The manufacturer then sets cleanability, air quality, materials, maintenance, qualification, and monitoring through product requirements, risk assessment, and validation.

Pharmaceutical packaging covers non-sterile oral solid-dose bottle lines and sterile aseptic vial lines. Annex 1 applies to sterile medicinal products. Its contamination-control principles may be applied to some non-sterile products only when the manufacturer documents and demonstrates that choice, not by default.

Station and pneumatic-task map

The table does not prescribe a component. It identifies the questions that must be answered before selecting one.

Divide the machine into risk zones

A component may cross boundaries through its exhaust, tube, cable, maintenance access, or leakage path. Installation location is therefore as important as the product name. Festo's cleanroom guidance also notes that cleanroom suitability depends on installation position and operating parameters. A cleanroom classification from a component test is not the pharmaceutical site's process validation.

How pneumatic components are normally used

Cylinders and guided drives move stops, gates, chucks, clamps, reject mechanisms, and secondary-packaging tooling. Choose them by force, stroke, speed, side load, guidance, cushioning, cleaning exposure, and exact declarations. A material label such as stainless steel or FKM is not proof of cleaning, cleanroom, or product compatibility; check the complete assembly and declaration.

Directional valves switch actuators. A terminal can reduce tubing and centralize diagnostics. Locate it based on contamination, heat, access, exhaust, and cabling, using exact ratings and instructions rather than a universal IP or coil rule.

Tubing and fittings carry pilot or working air. Size and select them for pressure, flow, chemicals, cleaning, bend radius, and retention. Label routes, protect open ends, and assess whether exhaust paths can retain contamination or alter timing.

Air preparation conditions the pneumatic supply. Keep product-contact process gas separate and clearly identified from actuator pilot air. Specify pressure, dew point, particles, oil, and other relevant contaminants at the process owner's measurement point.

Air-quality decision checklist

ISO 8573-1 classifies compressed-air purity for particles, water, and oil and also identifies gaseous and microbiological contaminants. It provides a common language for specification and measurement. It does not assign one mandatory class to all pharmaceutical uses. Festo publishes typical air-preparation examples, but its own operating-conditions document states that such values are approximate and each application must be tested by the operator.

Use this sequence:

1. Draw every air use and exhaust point. Mark whether it is pilot air, actuator air, process gas, barrier gas, blow-off air, or vacuum exhaust.
2. Determine whether the gas or any component surface can contact exposed product, primary packaging, a sterilized surface, or a cleaner room. Include normal operation, failure, maintenance, and line clearance.
3. Let the pharmaceutical quality unit and process owner define chemical, particle, microbial, oil, water, and any product-specific limits. State where each limit applies.
4. Select generation, drying, filtration, distribution, point-of-use treatment, and monitoring that can meet those limits. Account for the pipework after the final filter.
5. Qualify the system and establish sampling points, methods, alert or action criteria, frequencies, trending, maintenance, and filter integrity tests where applicable.
6. Put component or routing changes through change control and assess the effect on qualified state and contamination controls.

For sterile manufacture, EU GMP Annex 1 section 6.18 requires gas that directly contacts product or primary-container surfaces to have appropriate chemical, particle, and microbial quality, with relevant parameters such as oil and water specified. Section 6.19 adds requirements for gases used in aseptic processing, including sterilizing-grade filtration at the point of use and periodic microbial monitoring. Those clauses do not establish ISO 8573-1 Class 1.2.1 as a universal baseline. The actual specification comes from the use, product requirement, system design, and risk assessment.

Worked decision example: an oral solid-dose bottle line

Consider three uses. A cylinder rejects a capped, closure-verified bottle behind a guard, with no intended path to the open bottle. Specify motion, access, exhaust routing, and cleaning-zone compatibility; do not automatically treat it as direct-contact process gas.

An air jet above an open bottle can reach tablets. Quality must decide acceptability, specify particles, microorganisms, oil, and water, define point-of-use treatment and monitoring, and validate the process. Later nozzle or filter replacement is a controlled change.

An external-cabinet valve terminal powers several actuators. Select it for actual cabinet temperature, interface, maintenance, pressure, flow, alarms, and common-fault consequences. Do not copy an exposed-equipment IP rating without checking cabinet conditions.

A shared compressor does not mean shared risk. Preserve the distinction in the utility drawing and zone map.

Qualification and validation boundary

Annex 15 requires risk-based qualification and validation of critical aspects and significant quality-relevant changes. Depending on the site's quality system, a line lifecycle may cover user requirements, design review, installation and operational qualification, performance qualification, calibration, applicable cleaning validation, maintenance, periodic review, and change control.

A data sheet supports but does not replace that work. A compliant component can still fail after installation. For replacements, compare function, materials, lubricant, flow, leakage, timing, heat, electrical interface, diagnostics, environmental rating, cleaning, software or parameter effects, and traceability. Decide whether requalification is required before release.

Machine safety is separate from product-quality validation. Guarding, stored energy, vertical loads, restart, and maintenance access require risk assessment and verified protection. Both product and personnel protection must pass.

Information needed for an inquiry

Provide the pharmaceutical dosage form, sterile or non-sterile status, factory and line, station, machine function, zone drawing, whether gas or surfaces can contact product or primary packaging, required air specification and measurement point, cleaning and disinfection agents, temperature, cleanroom or environmental classification, exact current part number, material and lubricant restrictions, pressure, flow and cycle data, electrical interface, exhaust route, maintenance method, validation status, and change-control requirements. Include clear nameplate photographs and the approved component specification when replacing a part.

WarriorZ is an independent sourcing and model-identification support company. It is not Festo, a pharmaceutical manufacturer, or a validation authority. WarriorZ can help identify installed products, collect manufacturer documents, and source traceable components. The pharmaceutical manufacturer, machine builder, and quality unit decide suitability, GMP controls, risk acceptance, qualification, and release. Review pneumatic components, Festo sourcing support, equipment, or send the completed data through the inquiry form.